| Literature DB >> 18305221 |
Yasunori Saitoh1, Norio Yamamoto, M Zahidunnabi Dewan, Haruyo Sugimoto, Vicente J Martinez Bruyn, Yuki Iwasaki, Katsuyoshi Matsubara, Xiaohua Qi, Tatsuya Saitoh, Issei Imoto, Johji Inazawa, Atae Utsunomiya, Toshiki Watanabe, Takao Masuda, Naoki Yamamoto, Shoji Yamaoka.
Abstract
The nuclear factor-kappaB (NF-kappaB) transcription factors play important roles in cancer development by preventing apoptosis and facilitating the tumor cell growth. However, the precise mechanisms by which NF-kappaB is constitutively activated in specific cancer cells remain largely unknown. In our current study, we now report that NF-kappaB-inducing kinase (NIK) is overexpressed at the pretranslational level in adult T-cell leukemia (ATL) and Hodgkin Reed-Sternberg cells (H-RS) that do not express viral regulatory proteins. The overexpression of NIK causes cell transformation in rat fibroblasts, which is abolished by a super-repressor form of IkappaBalpha. Notably, depletion of NIK in ATL cells by RNA interference reduces the DNA-binding activity of NF-kappaB and NF-kappaB-dependent transcriptional activity, and efficiently suppresses tumor growth in NOD/SCID/gammac(null) mice. These results indicate that the deregulated expression of NIK plays a critical role in constitutive NF-kappaB activation in ATL and H-RS cells, and suggest also that NIK is an attractive molecular target for cancer therapy.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18305221 DOI: 10.1182/blood-2007-09-110635
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113